Clinical Trials Logo

Clinical Trial Summary

To determine the safety and effectiveness of Restylane® when used for lip augmentation.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00935272
Study type Interventional
Source Medicis Global Service Corporation
Contact
Status Completed
Phase N/A
Start date July 2009
Completion date July 2010

See also
  Status Clinical Trial Phase
Completed NCT04540913 - RHA® 3 Versus Restylane-L® for Lip Augmentation
Completed NCT03320824 - New Dermal Filler for Lip Augmentation N/A
Completed NCT05730543 - Ethnic Lip Augmentation With Hyaluronic Acid Filler Phase 3
Completed NCT04839692 - Assessment and Augmentation of Lip Appearance in Specific Study Populations Phase 4
Completed NCT03967444 - Study to Evaluate Satisfaction After Treatment With Kysse N/A
Terminated NCT04299295 - To Evaluate the Performance and Safety of YVOIRE Y Solution 360 Versus Comparator for Lips and Perioral Area. N/A
Completed NCT01629134 - Postmarket Study of JUVÉDERM VOLBELLA™ With Lidocaine in the Lips N/A
Terminated NCT04029545 - A Multicenter, Double-blind, Randomized, Controlled, Roll-over Retreatment Study of the Safety and Pain Associated With Injections of PN40082, RV001 With Topical Anesthetic or RV001 for Lip Augmentation Phase 3
Active, not recruiting NCT05342753 - Safety and Effectiveness of Restylane® Kysse for Lip Augmentation in Chinese Subjects N/A
Recruiting NCT05314504 - Clinical Investigation of YVOIRE Y-Solution 360 for Lip Augmentation in China N/A
Completed NCT04029519 - A Multicenter, Open-Label Retreatment Study of the Safety and Effectiveness of PN40082 for Lip Augmentation Phase 3
Completed NCT03796728 - A Study to Evaluate the Effectiveness of Juvéderm® VOLIFT™ With Lidocaine for Lip Augmentation Phase 4
Completed NCT01197495 - Safety and Effectiveness of Juvederm(R) Ultra XC Injectable Gel for Lip Augmentation N/A